ERCC6L2 and Fanconi anemia: While our understanding of ERCC6L2‐mediated predisposition to myeloid disease is still evolving, the link between impaired DNA damage repair factors and inherited BMF syndromes is already well established and drives the phenotype of Fanconi anaemia (FA) and DNA Ligase IV Deficiency syndrome.23, 24